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Saffron and its constituents have been shown to decrease ischemia-reperfusion (I/R) injury in
kidney or brain tissues. In this study, the effects of saffron ethanolic extract and its constituents,
crocin and safranal, were evaluated in skeletal muscle during I/R injury. Hind limb ischemia was
induced using clamping the common femoral artery and vein. After 2h ischemia, the clamp of
the femoral vessels of animals was taken off and the animal underwent 1h reperfusion. Muscle
injuries were evaluated by recording of the electromyographic (EMG) potentials and performing
some biochemical analysis including thiobarbituric acid reactive substances (TBARS), total
sulfhydryl (SH) groups and antioxidant capacity of muscle (using FRAP assay). The ethanolic
extract of saffron (5, 20 and 80mgkg
 1), crocin (50, 200 and 400mgkg
 1), safranal (0.1, 0.25 and
0.5mlkg
 1) and normal saline (10mlkg
 1) were administered intraperitoneally 1h prior
reperfusion. The average peak-to-peak amplitude during I/R was significantly increased in
extract, crocin and safranal groups in comparison with control-ischemic group. Following saffron,
crocin and safranal administration, the total SH contents and antioxidant capacity were elevated
in muscle flap. The MDA level was declined significantly in test groups. It is concluded that saffron
extract and its constituents show a protective effect against lower limb I/R in rat.
Keywords: Saffron (Crocus sativus L.)–Crocin–Safranal–Oxidative stress–Lower limb
ischemia–Reperfusion
Introduction
Skeletal muscle ischemia and reperfusion injury remain
an issue of concern because of the morbidity and
mortality that follows revascularization of an acutely
ischemic limb (1). Many studies have suggested the
beneficial effects of nutrients or other agents such as
vitamin E (2), C (3), green tea extract (2), melatonin
(4,5), carbenoxolone (6) and green propolis (7,8) in
reducing or preventing cerebral or muscle injury during
ischemia.-reperfusion (I/R).
Crocus sativus L. commonly known as saffron, is a
perennial stemless herb of the Iridaceae family and widely
cultivated in Iran and other countries such as India and
Greece (9). Commercial saffron comprises the dried red
stigma with a small portion of the yellowish style
attached. Compounds considered pharmacologically
active and important are volatile agents (e.g. safranal),
bitter principles (e.g. picrocrocin) and dye materials
(e.g. crocetin and its glycoside, crocin) (9). In modern
pharmacological studies, saffron, or its active constitu-
ents, has demonstrated anticonvulsant (10), antidepres-
sant (11), anti-inflammatory (12) and antitumour
activities (13,14). Radical scavenger effects as well as
learning and memory improving properties (15,16) and
promote the diffusivity of oxygen in different tissues were
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properly cited.also reported (9). Saffron extract is also chemopreventive
and showed protective effects on genotoxins-induced
oxidative stress in Swiss albino mice (17–19).
Recently, Assimopoulou et al. (20) showed that the
saffron extract, crocin and safranal exhibited significant
radical scavenging activity and thus antioxidant activity.
There was also a constant decrease in lipoprotein
oxidation susceptibility in healthy individuals after
administration of 50mg of saffron twice a day (21).
Saffron and its constituents have been shown to decrease
I/R injury in kidney (22) or brain tissues (23). Thus, in
this study the effect of saffron extract and its constituents
was evaluated during I/R on an animal model of I/R
injury in another tissue, the rat hind limb. Ischemia
damages were evaluated using recording of EMG
potentials (to show the viability of nerve) and measuring
oxidative markers. Malondialdehyde and SH-groups were
measured as parameters for lipid peroxidation and
oxidative-stress markers (24). Antioxidant capacity of
muscle was evaluated using FRAP assay (24).
Method
Animals
Male Wistar rats, 200–250g were housed in colony rooms
with 12/12h light/dark cycle at 21 2 C and had free
access to food and water. All animal experiments were
carried out in accordance with Mashhad University of
Medical Sciences, Ethical Committee Acts.
Materials
Safranal and crocin were obtained from Fluka. DTNB
(2, 20-dinitro-5, 50-dithiodibenzoic acid), TPTZ (2, 4, 6-tri
(2-pyridyl)-1, 3, 5-triazine), TBA (2-thiobarbituric acid),
n-butanol, Tris, Na2EDTA, sodium acetate, glacial acetic
acid, phosphoric acid, potassium chloride, tetramethox-
ypropane (TMP), ferric chloride (FeCl3.6H2O), ferrous
sulfate and hydrochloric acid was obtained from Merck.
Xylazine and ketamine were obtained from Loughrea,
Co. (Galway, Ireland) and Rotexmedica (GmbH,
Germany), respectively. For dilution, saffron and crocin
were dissolved in distilled water.
Induction of Ischemia
The rats were anesthetized with intraperitoneal injection
of ketamine/xylazine (60mgkg
 1 and 6mgkg
 1, respec-
tively). Additional doses of these agents were used if
anesthesia lightened during experiment.
An incision in the inner side of the hind leg from
the inguinal ligament to the tendon calcaneus insertion
was made.
Then it was divided up and the triceps surae was
dissected as a muscle flap, after that insertions to femur
was cut. Previously dissected femoral vessels, the artery
and vein were clamped with a single clamp of micro-
surgery. The absence of bleeding was verified in the
muscle flap. Then the incision was closed to prevent
desiccation. For reperfusion periods, the clamp of the
femoral vessels of animals was taken off and then the
bleeding of the muscle flap was verified (6). The muscle
tissues was homogenized in cold KCl solution (1.5%) to
give a 10% homogeny suspension and used for biochem-
ical assays. The results were expressed by n or micro-
molar tissue (1ml of homogenate=0.1g of tissue).
In some references these data are expressed as n or
mM/g protein.
Experimental Protocol
Eleven groups of animals were used, each of which
contained 8 rats: Group 1 including sham operated
animals, group 2 served as ischemic control to which
saline (10ml/kg
 1) was injected intraperitoneally (i.p.).
Group 3–5 was received the ethanolic extract of saffron
(5, 20 and 80mgkg
 1). Crocin was injected to group 6–8
(50, 200 and 400mgkg
 1) and safranal (0.1, 0.25 and
0.5mlkg
 1) was administered to group 9–11. All drugs
were administrated intraperitoneally 1h before
reperfusion.
The hind legs of groups 2–11 were exposed to 2h
ischemia and 1h reperfusion.
Electromyography Data Collection
To determine the muscles and nerve activities during I/R,
intramuscular electromyograph (EMG) signals were
recorded with PowerLab data acquisition systems.
Two pairs of pin electrodes in terminating alligator
clips were inserted into the triceps surae (muscle flap)
in hind leg, and adductor muscles. The distance between
the two electrodes of a pair in each muscle was 5mm. A
grounding electrode was gently attached to the rat tail
(25). The EMG signals were collected with sampling
frequency of 12 PPM (MacLab/4SP). Duration for each
stimulation was 20ms. The raw EMG signals were low-
pass filtered at 50Hz and EMG signal was expressed as
average peak-to-peak amplitude for a 10min recording
periods.
Preparation of Saffron Extract
Crocus sativus L. stigmas were collected from Ghaen
(Khorasan province, Northeast of Iran). In the macer-
ation method, 10g of stigmas were macerated in 500ml
ethanol (80 v/v) for three days. The mixture was
subsequently filtered and concentrated under reduced
pressure at 40 C. The extract yield was 52% w/w.
344 Anti-ischemic effect of saffronSaffron sample was analyzed according to the ISO 3632-
2: Bitterness, expressed as direct reading of the absorbance
of picrocrocine at about 257nm, on dry basis was 96.9;
safranal, expressed as direct reading of the absorbance at
about 330nm, on dry categories was 41.5 and coloring
strength, expressed as direct reading of the absorbance of
crocin at about 440nm, on dry basis was 259.
Biochemical Assays
Thiobarbituric Acid Reactive Species (TBARS)
Measurement
Malondialdehyde (MDA) levels, as an index of lipid
peroxidation, were measured. MDA reacts with thio-
barbituric acid (TBA) as a thiobarbituric acid reactive
substance (TBARS) to produce a red colored complex
which has peak absorbance at 532nm (26).
3ml phosphoric acid (1%) and 1ml TBA (0.6%) was
added to 0.5ml of muscle homogenate in a centrifuge tube
and the mixture was heated for 45min in a boiling water
bath. After cooling, 4ml of n-butanol was added the
mixture and vortex-mixed for 1min followed by centri-
fugation at 20000rpm for 20min. The organic layer
was transferred to a fresh tube and its absorbance was
measured at 532nm. The standard curve of MDA was
constructed over the concentration range of 0–40mM (27).
Ferric Reducing/Antioxidant Power (FRAP) Assay
The FRAP assay measures the change in absorbance
at 593nm owing to the formation of a blue colored
Fe
II-tripyridyltriazine compound from the colorless
oxidized Fe
III form by the action of electron donating
antioxidants (28).
The FRAP reagent consist of 300mM acetate buffer
(3.1g sodium acetate+16ml glacial acetic acid, made
up to 1l with distilled water; pH=3.6), 10mM TPTZ
in 40mM HCl and 20mM FeCl3.6H2O in the ratio
of 10:1:1.
Briefly, 50ml of muscle homogenate was added to
1.5ml freshly prepared and prewarmed (37 C) FRAP
reagent in a test tube and incubated at 37 C for 10min.
The absorbance of the blue colored complex was read
against reagent blank (1.5ml FRAP reagent+50ml
distilled water) at 593nm. Standard solutions of Fe
II in
the range of 100 to 1000mM were prepared from ferrous
sulphate (FeSO4.7H2O) in distilled water. The data was
expressed as mM ferric ions reduced to ferrous form per
liter (FRAP value) (29).
Total Sulfhydryl (SH) Groups Assay
Total SH groups were measured using DTNB
(2, 20-dinitro-5, 50-dithiodibenzoic acid) as the reagent.
This reagent reacts with the SH groups to produce a
yellow colored complex which has a peak absorbance
at 412nm (30).
Briefly, 1ml Tris-EDTA buffer (pH=8.6) was added
to 50ml muscle homogenate in 2ml cuvettes and sample
absorbance was read at 412nm against Tris-EDTA buffer
alone (A1). Then 20ml DTNB reagent (10mM in
methanol) was added to the mixture and after 15min
(stored in laboratory temperature) the sample absorbance
was read again (A2). The absorbance of DTNB reagent
was also read as a blank (B). Total thiol concentration
(mM) was calculated from the following equation:
TotalthiolconcentrationðmMÞ¼ðA2 A1 BÞ 
1:07
0:05
 13:6
Statistical Analysis
Data are expressed as mean SEM. Statistical analysis
was performed using one-way ANOVA followed by
Tukey–Kramer post-hoc test for multiple comparisons.
The P-values less than 0.05 were considered to be
statistically significant.
Results
Electromyography Data
The average peak-to-peak amplitudes in the control-
ischemic group and sham were 1.71 0.03, 1.57 0.068V
and 2.03 0.03, 2.06 0.63V) respectively during ische-
mia and reperfusion. The ethanolic extract of saffron,
crocin and safranal increased the amplitude compare with
ischemia and reperfusion groups (Table 1).
Thiobarbituric Acid Reactive Species (TBARS)
Measurement
There was an increase in the MDA levels following I/R
as compared with sham-operated animals (Fig. 1). The
saffron extract, crocin and safranal pretreatment resulted
in a significant reduction in the free radical-mediated
lipid peroxidation as indicated by a decrease in the MDA
levels, at various dose levels (Figs 1, 2 and 3). In safranal-
pretreated groups, a reduction in TBARS levels was very
prominent in the higher doses.
Modulation of FRAP Value
I/R caused a significant reduction in FRAP value of
muscle homogenate samples as compared with sham-
operated animals (3.31 0.16 versus 2.45 0.17mmol/g
tissue, P<0.05) (Fig. 4). The ethanolic saffron extract,
crocin and safranal pretreatment increased antioxidant
power (FRAP value) of muscle homogenate samples
(Figs 4, 5 and 6).
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Following I/R injury, a significant reduction in total SH
groups (0.57 0.03 versus 0.31 0.02mM, P<0.01)
in muscle homogenate samples was observed (Fig. 7).
The ethanolic saffron extract, crocin and safranal
pretreatment caused a significant elevation in total thiol
concentration, as compared with control-ischemic group
(Figs 7, 8 and 9).
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Figure 3. Effect of safranal on lipid peroxidation following muscle
ischemia reperfusion injury. MDA levels were measured in 10%
homogenates of muscle samples from rats subjected to 120min of
ischemia and 60min of reperfusion. All drugs were administrated
intraperitoneally 60min prior to reperfusion. Values are mean SEM
(n=8). *P<0.05, ***P<0.001 as compared with vehicle
(normal saline) treated animals (One-way ANOVA followed by
Tukey–Kramer test).
Table 1. Effects of ethanolic saffron extract, crocin and safranal on
average peak-to-peak amplitudes of EMG signals, prior, during and
after ischemia-reperfusion in rat skeletal muscle
Group (n=8) Preischemia
(v)
Ischemia
(v)
Reperfusion
(v)
Ischemic-Saline
control (10mlkg
 1)
2.25 0.02 1.71 0.03 1.57 0.02
Sham-Saline 2.22 0.03 2.03 0.03* 2.06 0.63***
Ethanolic extract
5mgkg
 1
2.21 0.10 2.05 0.04** 2.06 0.04***
Ethanolic extract
20mgkg
 1
2.24 0.06 2.12 0.08*** 2.08 0.07***
Ethanolic extract
80mgkg
 1
2.26 0.04 2.13 0.1** 2.09 0.06***
Crocin 50mgkg
 1 2.26 0.03 2.02 0.09* 2.01 0.03***
Crocin 200mgkg
 1 2.27 0.03 2.05 0.08* 2.05 0.04***
Crocin 400mgkg
 1 2.26 0.03 2.05 0.09* 2.05 0.04***
Safranal 0.1mlkg
 1 2.25 0.03 2.04 0.15* 2.07 0.04***
Safranal 0.25mlkg
 1 2.25 0.03 2.04 0.06* 2.03 0.04***
Safranal 0.5mlkg
 1 2.26 0.03 2.17 0.23*** 2.17 0.04***
Values are mean S.E.M. *P<0.05, **P<0.01 and ***P<0.001 when
compared with corresponding between groups with Tukey–Kramer test.
V=volt.
0
10
20
30
40
50
Ischemic-Saline
Sham-Saline
Ethanolic Extract 5 mg/kg
Ethanolic Extract 20 mg/kg
Ethanolic Extract 80 mg/kg
*
   *
***
***
M
D
A
 
 
c
o
n
c
e
n
t
r
a
t
i
o
n
(
n
 
m
o
l
/
g
 
t
i
s
s
u
e
)
Figure 1. Effect of ethanolic saffron extract on lipid peroxidation
following muscle ischemia reperfusion injury. MDA levels were
measured in 10% homogenates of muscle samples from rats subjected
to 120min of ischemia and 60min of reperfusion. All drugs were
administrated intraperitoneally 60min prior to reperfusion. Values
are mean SEM (n=8). *P<0.05, ***P<0.001 as compared with
vehicle (normal saline) treated animals (One-way ANOVA followed by
Tukey–Kramer test).
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Figure 2. Effect of crocin on lipid peroxidation following muscle
ischemia reperfusion injury. MDA levels were measured in 10%
homogenates of muscle samples from rats subjected to 120min of
ischemia and 60min of reperfusion. All drugs were administrated
intraperitoneally 60min prior to reperfusion. Values are mean SEM
(n=8). *P<0.05, ***P<0.001 as compared with vehicle
(normal saline) treated animals (One-way ANOVA followed by
Tukey–Kramer test).
346 Anti-ischemic effect of saffronDiscussion
The results obtained in the present investigation suggest
that the saffron extract and its active constituents, crocin
and safranal, have an overall protective effect against
muscle I/R injury in a rat model.
A number of processes have been implicated in the
pathogenesis of oxygen deprivation-induced cell injury.
These include the disturbances of cell calcium homeo-
stasis, depletion of adenine nucleotides, activation of
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Figure 5. Effect of crocin on antioxidant power of muscle homogenate
samples following muscle ischemia reperfusion injury. FRAP values
were measured in 10% homogenate samples from rats subjected to
120min of ischemia and 60min of reperfusion. All drugs were
administrated intraperitoneally 60min prior to reperfusion. Values are
mean SEM (n=8). **P<0.01 as compared with vehicle
(normal saline) treated animals (One-way ANOVA followed by
Tukey–Kramer test).
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Figure 7. Effect of ethanolic saffron extract on total thiol concentra-
tions following muscle ischemia reperfusion injury. Total sulfhydryl
(SH) groups were measured in 10% muscle homogenate samples from
rats subjected to 120min of ischemia and 60min of reperfusion. All
drugs were administrated intraperitoneally 60min prior to reperfusion.
Values are mean SEM (n=8). *P<0.05, **P<0.01 as compared
with vehicle (normal saline) treated animals (One-way ANOVA
followed by Tukey–Kramer test).
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Figure 4. Effect of ethanolic saffron extract on antioxidant power of
muscle homogenate samples following muscle ischemia reperfusion
injury. FRAP values were measured in 10% homogenate samples from
rats subjected to 120min of ischemia and 60min of reperfusion. All
drugs were administrated intraperitoneally 60min prior to reperfusion.
Values are mean SEM (n=8). *P<0.05, **P<0.01 as compared
with vehicle (normal saline) treated animals (One-way ANOVA
followed by Tukey–Kramer test).
0
1
2
3
4
5
Ischemic-Saline
Sham-Saline
Safranal 0.1 ml/kg
Safranal 0.25 ml/kg
Safranal 0.5 ml/kg
*
*** ***
*
F
R
A
P
 
v
a
l
u
e
(
m
 
m
o
l
/
g
 
t
i
s
s
u
e
)
Figure 6. Effect of safranal on antioxidant power of muscle homogenate
samples following muscle ischemia reperfusion injury. FRAP values
were measured in 10% homogenate samples from rats subjected to
120min of ischemia and 60min of reperfusion. All drugs were
administrated intraperitoneally 60min prior to reperfusion. Values are
mean SEM (n=8). *P<0.05, ***P<0.001 as compared with vehicle
(normal saline) treated animals (One-way ANOVA followed by Tukey–
Kramer test).
eCAM 2009;6(3) 347enzymes like phospholipases with production of toxic
lipid metabolites, proteases and endonucleases and
generation of free radicals (ROS) that can cause
oxidative damage to cellular macromolecules (31,32).
Antioxidant therapy has been well documented to help in
the improvement of organ functions (33).
We assessed the effect of the saffron extract, crocin and
safranal by studying their effects on lipid peroxidation.
MDA levels increased significantly following muscle I/R.
The saffron extract and its bioactive constituents reversed
the increase of MDA levels to a considerable extent,
thereby confirming its antioxidant role in I/R.
Under acute and chronic pathologic conditions such as
ischemia, the balance between oxidant and antioxidant
systems has been interrupted (34,35). Therefore we
evaluate the antioxidant or reducing potential of muscle
homogenate samples following muscle I/R, using FRAP
assay. As expected following this, a significant reduction
in antioxidant power, as indicated by FRAP value, was
observed. The extract, crocin and safranal increased the
antioxidant power of muscle homogenate samples.
Sulfhydryl (SH) groups are highly-reactive constituents
of protein molecules, and they participate in important
biochemical and metabolic process such as cell division,
blood coagulation, maintenance of protein systems and
enzymatic activation including antioxidant enzymes
(catalase, superoxide dismutase, etc.) (36). There are
also important scavengers of oxygen-derived free radicals
(37). SH groups known to be sensitive to oxidative
damage and depleted following ischemic insult (38),
therefore we studied the effect of these agents on total
thiol concentration during muscle I/R. Similarly, in our
studies, total sulfhydryl groups were decreased following
I/R injury. These agents exhibited higher SH contents in
muscle tissues than their respective controls, indicating
that helped in replenishing the total thiol pool.
As we said crocin and crocetin are main constituents
that have antioxidant activity, these means that these
components were studied for these effects. There are a lot
other ingredients in saffron extract which should evaluate
for this effect. In our study the saffron extract was more
potent than crocin. This may be attributed to a
synergistic action of many constituents such as crocins,
crocetin, dimethyl crocetin, safranal and flovonoids
which quench free radicals and have antioxidant effects
and may have role in protective effect of saffron on
muscle I/R. In addition saffron contains proteins, sugars,
vitamins (especially riboflavin), amino acids, minerals
and gums. Also it seems crocin from Fluka is not
completely pure.
Among the constituents of saffron stigmas, crocins and
crocetin are the most abundant agents with established
antioxidant and antitumor effects (9, 13 and 18). These
carotenoids scavenge free radicals, especially superoxide
anions and thereby may protect cells from oxidative stress
(39). The aqueous saffron extract and its active constituent,
crocin also prevent renal I/R-induced oxidative injury in
rats (22). In our study the saffron extract was more potent
than crocin. This may be attributed to a synergistic action
of many constituents such as crocins, crocetin, dimethyl
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Figure 9. Effect of safranal on total thiol concentrations following
muscle ischemia reperfusion injury. Total sulfhydryl (SH) groups were
measured in 10% muscle homogenate samples from rats subjected to
120min of ischemia and 60min of reperfusion. All drugs were
administrated intraperitoneally 60min prior to reperfusion. Values are
mean SEM (n=8). ***P<0.001 as compared with vehicle
(normal saline) treated animals (One-way ANOVA followed by
Tukey–Kramer test).
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Figure 8. Effect of crocin on total thiol concentrations following muscle
ischemia reperfusion injury. Total sulfhydryl (SH) groups were
measured in 10% muscle homogenate samples from rats subjected to
120min of ischemia and 60min of reperfusion. All drugs were admin-
istrated intraperitoneally 60min prior to reperfusion. Values are
mean SEM (n=8). ***P<0.01 as compared with vehicle
(normal saline) treated animals (One-way ANOVA followed by
Tukey–Kramer test).
348 Anti-ischemic effect of saffroncrocetin, safranal and flovonoids which quench free
radicals and have antioxidant effects and may have role in
protective effect of saffron on muscle I/R. In addition
saffron contains proteins, sugars, vitamins (especially
riboflavin), amino acids, minerals and gums (9). It is also
possible that crocin may be impure.
Safranal also showed anti-ischemia activity in this
study. This monoterpene aldehyde, which is the major
constituent of the essential oil of saffron (20) showed
good antioxidant activity. Our recent studies showed that
safranal also attenuated cerebral ischemia induced
oxidative damage in rat hippocampus (23). As safranal
showed suitable activity in almost all doses, it may be
concluded that safranal is major antioxidant constituent
or played a major role in protecting I/R-induced
oxidative injury. But it should be mentioned that safranal
is usually present in less than 1% of saffron extract (40).
It seems that I/R injury reduced the conductivity and
viability of muscles and nerves. In this study, the saffron
extract and its constituents maintained the nerve con-
ductivity. Nerve conduction is decreased during I/R
(41,42). Mild muscle necrotic changes occur after 2–3h
ischemia (43,44). Oxidative stress and the production
of oxygen free radicals during I/R is one mechanism
of ischemic fiber degeneration, causing a breakdown of
the blood-nerve barrier, endoneurial edema and lipid
peroxidation (45). Saffron and its constituents prevented
lipid peroxidation and showed antioxidant activity in this
study. These effects and other activities such as anti-
inflammatory effect (12) may preserve viability of nerve
conductivity. A reduction in the EMG potential was
more severe in reperfusion phase than the ischemia stage
as shown in another study (46).
In conclusion, the present study showed that saffron
extract and its constituents, crocin and safranal, have
protective effect on I/R injury-induced oxidative stress in
rats muscle that at least partly is due to antioxidant
properties of saffron and its constituents.
Acknowledgements
The authors are thankful to the Vice Chancellor of
Research, Mashhad University of Medical Sciences for
financial support.
References
1. Ascher E, Hanson JN, Cheng W, Hingorani A, Scheinman M.
Glycine preserves function and decreases necrosis in skeletal
muscle undergoing ischemia and reperfusion injury. Surgery
2001;129:231–5.
2. Ikeda K, Negishi H, Yamori Y. Antioxidant nutrients and hypoxia/
ischemia brain injury in rodents. Toxicology 2003;189:55–61.
3. Kearns SR, Daly AF, Sheehan K, Murray P, Kelly C, Bouchier-
Hayes D. Oral vitamin C reduces the injury to skeletal muscle
caused by compartment syndrome. J Bone Joint Surg Br
2004;86:906–11.
4. Erkanli K, Kayalar N, Erkanli G, Ercan F, Sener G, Kirali K.
Melatonin protects against ischemia/reperfusion injury in skeletal
muscle. J Pineal Res. 2005;39:238–42.
5. Wang WZ, Fang XH, Stephenson LL, Khiabani KT, Zamboni WA.
Melatonin reduces ischemia/reperfusion-induced superoxide genera-
tion in arterial wall and cell death in skeletal muscle. J Pineal Res
2006;41:255–60.
6. Hosseinzadeh H, Nassiri Asl M, Parvardeh S. The effects of
carbenoxolone, a semisynthetic derivative of glycyrrhizinic acid,
on peripheral and central ischemia-reperfusion injuries in the
skeletal muscle and hippocampus of rats. Phytomedicine
2005;12:632–7.
7. Inokuchi Y, Shimazawa M, Nakajima Y, Suemori S, Mishima S,
Hara H. Brazilian green propolis protects against retinal damage in
vitro and in vivo. Evid. Based Complement Alternat Med
2006;3:71–7.
8. Shimazawa M, Chikamatsu S, Morimoto N, Mishima S, Nagai H,
Hara H. Neuroprotection by Brazilian Green Propolis against In
vitro and In vivo Ischemic Neuronal Damage. Evid Based
Complement Alternat Med 2005;2:201–7.
9. Rı´os JL, Recio MC, Giner RM, Ma ´ n ˇ ez S. An update review of
saffron and its active constituents. Phytother Res 1996;10:189–93.
10. Hosseinzadeh H, Khosravan V. Anticonvulsant effects of aqueous
and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Irn
Med 2002;5:44–7.
11. Hosseinzadeh H, Karimi Gh, Niapoor M. Antidepressant effects of
Crocus sativus stigma extracts and its constituents, crocin and
safranal, in mice. Acta Hort 2004;650:435–45.
12. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-
inflammatory effects of Crocus sativus L. stigma and petal extracts
in mice. BMC Pharmacol 2002;2:1–8.
13. Abdullaev FJ. Biological effects of saffron. Biofactors 1993;4:83–6.
14. Escribano J, Alonso GL, Coca-Prados M, Fernandez JA. Crocin,
safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the
growth of human cancer cells in vitro. Cancer Lett 1996;100:23–30.
15. Zhang YX, Sugiura M, Saito H, Shoyama Y. Acute effects of
Crocus sativus L. on passive avoidance performance in mice. Biol
Pharmacol Bull 1994;17:217–21.
16. Abe K, Sugiura M, Ymaguchi S, Shoyama Y, Saito H. Saffron
extract prevents acetaldehyde-induced inhibition of long-term
potentiation in the rat dentate gyrus in vivo. Brain Res
1999;851:287–9.
17. Abdullaev J, Caballero-Ortega H, Riveron-Nigrete L, Pereda-
miranda R, Rivera-Luna R, Manuel Hernandez J, Perez-Lopez I,
Espinosa-Aguirre JJ. In vitro evaluation of chemopreventive
potential of saffron. Rev Inves Clin 2002;54:430–6.
18. Nair SC, Kurumboor SK, Hasegawa JH. Saffron chemoprevention
in biology and medicine: a review. Cancer Biother 1995;10:257–64.
19. Premkumar K, Abraham SK, Santhiya ST, Ramesh A. Protective
effects of saffron (Crocus sativus L.) on genotoxins-induced
oxidative stress in Swiss albino mice. Phytother Res 2003;17:614–17.
20. Assimopoulou AN, Sinakos Z, Papageorgiou VP. Radical scaveng-
ing activity of Crocus sativus L. extract and its bioactive
constituents. Phytother Res 2005;19:997–1000.
21. Verma SK, Bordia A. Antioxidant property of saffron in man.
Indian J Med Sci 1998;52:205–7.
22. Hosseinzadeh H, Sadeghnia HR, Ziaee T, Danaee A. Protective
effect of aqueous saffron extract (Crocus sativus L.) and crocin, its
active constituent, on renal ischemia-reperfusion-induced oxidative
damage in rats. J Pharm Pharmacol Sci 2005;8:387–93.
23. Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus
sativus (saffron) attenuated cerebral ischemia induced oxidative
damage in rat hippocampus. J Pharm Pharmacol Sci 2005;8:394–9.
24. Huang D, Ou B, Prior RL. The chemistry behind antioxidant
capacity assays.. J Agric Food Chem 2005;53:1841–56.
25. Ossowska K, Lorence-Koci E, Schulze G, Wolfarth S. The influence
of dizolcipine (MK-801) on the reserpine-enhanced electromyo-
graphic stretch reflex in rats. Neurosci Lett 1996;203:73–6.
26. Fernandez J, Perez-Alvarez JA, Fernandez-lopez JA. Thiobarbituric
acid test for monitoring lipid oxidation in meat. Food Chem
1997;99:345–53.
27. Uchiama M, Miahara M. Determination of malonaldehyde
precursor in tissues by thiobarbituric acid test. Anal Biochem
1978;86:279–86.
eCAM 2009;6(3) 34928. Benzie IFF, Strain J. The ferric reducing ability of plasma (FRAP)
as a measure of antioxidant power: the FRAP assay. Anal Biochem
1996;239:70–6.
29. Benzie IFF, Strain JJ. Ferric reducing/antioxidant power assay:
direct measure of total antioxidant activity of biological fluids and
modified version for simultaneous measurement of total antioxidant
power and ascorbic acid concentration. Methods Enzymol
1999;299:15–27.
30. Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys
1959;82:70–7.
31. Rhodena E, Teloken C, Lucas M, Rhoden C, Mauri M, Zettler C,
Bello-Kleind A, Barros E. Protective effect of allopurinol in the
renal ischemia–reperfusion in uninephrectomized rats. General
Pharmacol 2002;35:189–93.
32. Montagna G, Hofer CG, Torres AM. Impairment of cellular redox
status and membrane protein activities in kidneys from rats with
ischemic acute renal failure. Biochem Biophys Acta
1998;1407:99–108.
33. Lee JY, Lott JA, Kauffman EM, Sharma HM. Effect of herbal
mixture MAK-4 on organ functions in WHHL rabbits. Biochem
Arch 1997;13:285–96.
34. Abdollahi M, Ranjbar R, Shadnia S, Nikfar S, Rezaie A. Pesticides
and oxidative stress: a review. Med Sci Monit 2004;10:141–7.
35. Parihar MS, Hemnani T. Phenolic antioxidants attenuate hippo-
campal neuronal cell damage against kainic acid induced excito-
toxicity. J Biosci 2003;28:121–8.
36. Jansen EV. Sulfhydryl-disulfide interchanges. Science 1959;
130:1319–23.
37. Dormandy TL. An approach to free radicals in medicine and
biology. Acta Physiol Scand 1980;492:153–68.
38. Soszynski M, Bartosz G. Decrease in accessible thiols as an index of
oxidative damage to membrane proteins. Free Rad Biol Med
1980;23:463–9.
39. Bors W, Saran M, Michel C. Radical intermediates involved in the
bleaching of the carotenoid crocin. Hydroxyl radicals, superoxide
anions and hydrated electrons. Int J Radiat Biol Relat Stud Phys
Chem Med 1982;41:493–501.
40. Caballero-Ortega H, Pereda-Miranda R, Abdullaev FI. HPLC
quantification of major active components from 11 different saffron
(Crocus sativus L.) sources. Food Chem 2007;100:1126–31.
41. Oguzhanoglu A, Kurt T, Sahiner T. Nerve conduction parameters
during ischemia-reperfusion in the rat sciatic nerve. Electromyogr
Clin Neurophysiol 2000;40:487–90.
42. Schmelzer JD, Zochodne DW, Low PA. Ischemic and reperfusion
injury of rat peripheral nerve. Proc Natl Acad Sci USA
1989;86:1639–42.
43. Korthals JK, Maki T, Gieron MA. Nerve and muscle vulnerability
to ischemia. J Neurol Sci 1985;71:283–90.
44. Iida H, Schmelzer JD, Schmeichel AM, Wang Y, Low PA.
Peripheral nerve ischemia: reperfusion injury and fiber regeneration.
Exp Neurol 2003;184:997–1002.
45. Nagamatsu M, Schmelzer JD, Zollman PJ, Smithson IL,
Nickander KK, Low PA. Ischemic reperfusion causes lipid
peroxidation and fiber degeneration. Muscle Nerve 1996;19:37–47.
46. Mitsui Y, Schmelzer JD, Zollman PJ, Mitsui M, Tritschler HJ,
Low PA. Alpha-lipoic acid provides neuroprotection from
ischemia-reperfusion injury of peripheral nerve. J Neurol Sci
1999;163:11–6.
Received July 5, 2006; accepted June 9, 2007
350 Anti-ischemic effect of saffron